Your browser doesn't support javascript.
loading
Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F.
Ge, Xiao-Lei; Li, Si-Zhe; Jin, Xinxing; Jin, Hong-Zhong; Zuo, Ya-Gang.
Afiliação
  • Ge XL; Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Translational Medicine Center of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li SZ; Department of Dermatology, Hebei North University, Zhangjiakou, Hebei, China.
  • Jin X; Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Translational Medicine Center of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jin HZ; Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Translational Medicine Center of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zuo YG; Department of Dermatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Translational Medicine Center of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dermatol Ther ; 33(4): e13721, 2020 07.
Article em En | MEDLINE | ID: mdl-32500934
ABSTRACT
Tripterygium wilfordii Hook F (TwHF) is a traditional Chinese herb used in many medicinal applications, but the treatment of bullous pemphigoid (BP) with TwHF has never been reported. The aim of this study was to evaluate the efficacy and safety of TwHF in BP patients. A retrospective study was performed from January 2015 to September 2019 in the Department of Dermatology, Peking Union Medical College Hospital. A total of 10 patients with mild to moderate BP and treated with TwHF were enrolled in the study with 10 mild or moderate BP patients treated with systemic glucocorticoid randomly selected as controls. In the TwHF group, a major response was seen in seven patients, a minor response in one and no response was seen in two patients. In the glucocorticoid group, a major response was seen in nine patients and a minor response in one patient. Two patients experienced treatment failure. The time to disease control in the TwHF group (34 ± 11 days) was longer as compared to the glucocorticoid group (18 ± 8 days, P < .05). Ten patients relapsed during the follow-up period. The adverse events in the TwHF group were lower than those in the glucocorticoid group (13 vs 19). Low-dose TwHF may be effective and safe for treating mild and moderate BP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Penfigoide Bolhoso / Tripterygium Tipo de estudo: Diagnostic_studies / Observational_studies País/Região como assunto: Asia Idioma: En Revista: Dermatol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Penfigoide Bolhoso / Tripterygium Tipo de estudo: Diagnostic_studies / Observational_studies País/Região como assunto: Asia Idioma: En Revista: Dermatol Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China